thiophenes has been researched along with Respiratory Tract Diseases in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aparici, M; Carcasona, C; Cortijo, J; Doe, C; Gavaldà, A; Miralpeix, M; Montero, JL; Ortiz, JL; Puig, C; Ramos, I; Vilella, D | 1 |
Cella, SG; Dal Negro, R; Pozzi, E | 1 |
Bhatnagar, A; Billeter, AT; Hellmann, JL; Polk, HC | 1 |
Adcock, IM; Belvisi, MG; Birrell, MA; Catley, MC; Davies, M; Eltom, S; Evans, SM; Grace, M; Kilty, I; Lawrence, T; Pasparakis, M; Rastrick, JM; Stevenson, CS | 1 |
Medici, TC; Radielovic, P; Steiner, A | 1 |
Arpurt, JP; Bianchi, D; Chichmanian, R; Delmont, J; Hastier, P; Kuhdorf, H; Saint-Paul, MC | 1 |
Fazzio, S; Lizzio, A; Mancini, C; Negri, P; Termini, C; Titti, G | 1 |
Arimura, A; Arita, H; Asanuma, F; Hasegawa, H; Kakudo, S; Kishino, J; Ohtani, M; Yasui, K | 1 |
Messmer, E | 1 |
2 review(s) available for thiophenes and Respiratory Tract Diseases
Article | Year |
---|---|
Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Expectorants; Humans; Mucociliary Clearance; Mucus; Polypharmacy; Respiratory Tract Diseases; Thioglycolates; Thiophenes | 2018 |
Transient receptor potential ion channels: powerful regulators of cell function.
Topics: Analgesics; Anti-Inflammatory Agents; Biomarkers; Calcium Channels; Capsaicin; Chronic Pain; Duloxetine Hydrochloride; Humans; Inflammation; Macrophages; Melanoma; Monocytes; Nerve Tissue Proteins; Pain, Postoperative; Respiratory Tract Diseases; Surgical Wound Infection; Thiophenes; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels | 2014 |
2 trial(s) available for thiophenes and Respiratory Tract Diseases
Article | Year |
---|---|
[Short-term effect of ketotiphen on physicochemical sputim characteristics in patients with chronic reversible respiratory diseases].
Topics: Adult; Aged; Drug Administration Schedule; Female; Fucose; Glycoproteins; Humans; Immunoglobulin A; Ketotifen; Male; Middle Aged; Piperidines; Respiratory Tract Diseases; Sialic Acids; Sputum; Thiophenes; Viscosity | 1980 |
A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Topics: Administration, Oral; Anti-Bacterial Agents; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Expectorants; Female; Fever; Humans; Infant; Male; Respiratory Tract Diseases; Thioglycolates; Thiophenes; Treatment Outcome | 2000 |
5 other study(ies) available for thiophenes and Respiratory Tract Diseases
Article | Year |
---|---|
Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β
Topics: Acetylcholine; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Animals; Bronchoconstriction; Cyclohexanes; Dogs; Guinea Pigs; Half-Life; Humans; Inhibitory Concentration 50; Male; Muscarinic Antagonists; Quinolines; Receptor, Muscarinic M3; Respiratory Tract Diseases; Thiophenes | 2017 |
Cigarette smoke induced airway inflammation is independent of NF-κB signalling.
Topics: Amides; Animals; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Gene Expression; Humans; I-kappa B Kinase; Immunohistochemistry; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Nicotiana; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smoke; Smoking; Thiophenes; Time Factors; Transcription Factor RelA | 2013 |
[Thiophene-induced hepatitis: a new case].
Topics: Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Respiratory Tract Diseases; Thiophenes | 1993 |
Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751.
Topics: Animals; Blood Platelets; Cell Membrane; Conjunctivitis; Cyclic AMP; Guinea Pigs; HL-60 Cells; Humans; Hypersensitivity; In Vitro Techniques; Inflammation; Ligands; Male; Prostaglandin Antagonists; Receptors, Prostaglandin; Respiratory Tract Diseases; Rhinitis, Allergic, Seasonal; Thiophenes | 2001 |
Studies with the new medium tranquilizer 4-(3-dimethylaminopropylidene)-9-10-dihydro-4H-benzo(4,5)cycloheptal(1,2-b)thiophene (IB-503) in internal medicine.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Middle Aged; Psychophysiologic Disorders; Respiratory Tract Diseases; Thiophenes; Tranquilizing Agents | 1969 |